Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Operating Expenses | 11,010 | 17,116 | 12,935 | 0 |
| Operating Income | -11,010 | -17,116 | -12,935 | N/A |
| Interest Expense | 793 | 0 | 0 | 0 |
| Other Income | 1,313 | 1,060 | -111 | 0 |
| Pre-tax Income | -10,490 | -16,056 | -13,045 | 0 |
| Net Income Continuous | -10,490 | -16,056 | -13,045 | N/A |
| Net Income | $-10,490 | $-16,056 | $-13,045 | $N/A |
| EPS Basic Total Ops | -13,462.53 | -15,663.41 | -59,223.69 | N/A |
| EPS Basic Continuous Ops | -13,469.63 | -71,476.25 | -58,842.03 | N/A |
| EPS Diluted Total Ops | -13,462.53 | -15,663.41 | -59,223.69 | N/A |
| EPS Diluted Continuous Ops | -13,469.63 | -71,476.25 | -58,842.03 | N/A |
| EBITDA(a) | $-10,986 | $-17,087 | $-12,914 | $N/A |